JPMorgan Chase & Co. Increases Option Care Health (NASDAQ:OPCH) Price Target to $40.00

Option Care Health (NASDAQ:OPCH) had its price target boosted by stock analysts at JPMorgan Chase & Co. from $38.00 to $40.00 in a research note issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 31.88% from the company’s current price.

Several other research analysts have also issued reports on OPCH. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research raised their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research note on Tuesday, January 14th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Truist Financial reduced their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

Option Care Health Price Performance

Shares of OPCH stock opened at $30.33 on Friday. The business’s fifty day moving average is $24.42 and its 200 day moving average is $27.82. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.16 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.11 and a beta of 1.31. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the period. GAMMA Investing LLC increased its position in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Lindenwold Advisors INC lifted its holdings in Option Care Health by 5.4% in the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after acquiring an additional 489 shares during the period. Pacer Advisors Inc. boosted its position in Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after purchasing an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management grew its stake in shares of Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.